首页 › 头颈鳞状细胞癌 › 北卡罗来纳州 › Charlotte
Charlotte NC 头颈鳞状细胞癌临床试验
10项针对 头颈鳞状细胞癌的研究正在 Charlotte及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
招募中1 期
- Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center, Huntersville · 距离 13 英里
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
招募中3 期
- Atrium Health Levine Cancer Institute, Charlotte
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
招募中1/2 期
- Carolina Biooncology Institute, Huntersville · 距离 13 英里
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
招募中1 期
- Carolina BioOncology Institute /ID# 272380, Huntersville · 距离 13 英里
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
招募中2 期
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Atrium Health Pineville/LCI-Pineville, Charlotte
- Atrium Health University City/LCI-University, Charlotte
- 以及另外 5 项
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
招募中1/2 期
- Carolina BioOncology Institute, Huntersville · 距离 13 英里
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
招募中1 期
- Carolina BioOncology Institute /ID# 232597, Huntersville · 距离 13 英里
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
招募中1/2 期
- Carolina BioOncology Institute, Huntersville · 距离 13 英里
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
招募中1 期
- Dren Investigational Site, Huntersville · 距离 13 英里
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
招募中1 期
- Levine Cancer Institute, Charlotte
其他城市的 头颈鳞状细胞癌试验
- Houston, TX47 项研究
- Los Angeles, CA42 项研究
- Boston, MA40 项研究
- New York City, NY39 项研究
- Nashville, TN39 项研究
- St. Louis, MO28 项研究
- Arlington, VA26 项研究
- Chicago, IL26 项研究
- Philadelphia, PA26 项研究
- Atlanta, GA24 项研究
- San Antonio, TX22 项研究
- New Haven, CT22 项研究
Charlotte的其他研究
- 癌症（所有类型）27 项研究
- 乳腺癌22 项研究
- 多发性骨髓瘤21 项研究
- 非小细胞肺癌19 项研究
- 急性髓系白血病16 项研究
- 肥胖症16 项研究
- 超重15 项研究
- 结直肠癌13 项研究
- 卵巢癌12 项研究
- 心力衰竭11 项研究
- 转移性癌症11 项研究
- 慢性阻塞性肺病9 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。